Rapid Acceleration Process for Intensive Treatment of PTSD in 5 Days
Part of paid clinical trials in Palo Alto, California.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT07167940
- Phase
- PHASE3
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Transcranial magnetic stimulation — DEVICEiTBS; 50 Hz triplets given at 5 Hz frequency with a cycle time of 2 seconds on and 8 seconds off). There will be 60 cycles for a total of 1800 pulses
- Sham transcranial magnetic stimulation — DEVICESham iTBS; 50 Hz triplets given at 5 Hz frequency with a cycle time of 2 seconds on and 8 seconds off). There will be 60 cycles for a total of 1800 pulses
Study Details
Veterans with posttraumatic stress disorder (PTSD) need more effective treatments. Existing options can have limited adherence and can be very time-consuming. As such, alternative interventions are needed. Transcranial magnetic stimulation (TMS) has been FDA-cleared for depression since 2008 and has recently been cleared to treat smoking cessation and obsessive-compulsive disorder. It has demonstrated promise for reducing PTSD symptom severity but standard TMS has a significant time requirement. This study will compare an accelerated 5-day form of TMS versus sham for PTSD, characterizing efficacy and durability. This project will provide important information that can be implemented in the near term for Veterans with PTSD.
Key Dates
- Start date
- Jul 1, 2026
- Status verified
- Mar 2026
- Primary completion
- Jun 30, 2030
- Completion
- Jul 1, 2030
Study Design
- Enrollment
- 90 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Active TMSActive transcranial magnetic stimulation
- Sham Comparator: Sham TMSNon-active/sham transcranial magnetic stimulation
Primary Outcome Measure
PTSD Checklist for the DSM-5 [ Time Frame: T1:Baseline, T2: Post-Treatment, T3: One month post treatment, & T4: 3 months post-treatment ]
Central Contacts
- Michelle R Madore, PhD(650) 493-5000
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| VA Palo Alto Health Care System, Palo Alto, CA | Palo Alto | California | 94304-1207 | Michelle R Madore, PhD (PRINCIPAL_INVESTIGATOR) |
| Providence VA Medical Center, Providence, RI | Providence | Rhode Island | 02908-4734 |
Find similar trials in Palo Alto, CA
Related Studies
- Local Participatory Systems Dynamics to Increase Reach of Evidence Based Addiction and Mental Health CareEnrolling By Invitation · Palo Alto Veterans Institute for Research · Palo Alto, California
- Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study)PHASE2 · Recruiting · VA Office of Research and Development · Tuscaloosa, Alabama
- Intracranial Neurophysiological Signatures of Fear and Anxiety in HumansRecruiting · Duke University · Los Angeles, California
- Facilitating Transition to Recommended PTSD TreatmentNot Yet Recruiting · VA Office of Research and Development · San Francisco, California